Cognitive impairment among Type 2 diabetic older adults: A single-centered cross-sectional study
DOI:
https://doi.org/10.33897/fujrs.v6i1.394Keywords:
Cognitive impairment, mini-mental state examination, older adults, type 2 diabetesAbstract
Background: Type 2 diabetes mellitus (T2DM) is a metabolic disorder characterized by hyperglycemia due to insulin resistance or deficiency. Cognitive impairment in older adults with T2DM can significantly hinder daily activities and self-care.
Objective: To assess the prevalence of cognitive impairment among older adults with T2DM.
Methods: A six-month descriptive cross-sectional study was conducted at Ghurki Trust and Teaching Hospital (April-October 2018). Using consecutive sampling, 91 older adults with T2DM were recruited from the diabetic clinic. Exclusion criteria included other major systemic diseases, cognitive impairment from a known non-diabetic cause, and type 1 diabetes. The study was approved by the Ethics Committee of Lahore College of Physical Therapy (LCPT/DPT/19/418). and informed consent was obtained. Cognitive function was assessed using the Mini-Mental State Examination (MMSE), with impairment categorized as: none (?24), mild (18-23), and moderate-severe (?17). Data were analyzed using SPSS version 21. Key limitation is the use of a single-center, non-probability sample.
Results: Among the 91 participants, 38.5% 9(n=35) exhibited no cognitive impairment, as indicated by MMSE scores between 24 and 30. Mild cognitive impairment was the most prevalent category, affecting 59.3% (n=54) of participants, while moderate cognitive impairment was identified in 2.2% (n=2). No cases of severe cognitive impairment were observed. Overall, cognitive impairment (MMSE ? 23) was present in 61.5% of the study population.
Conclusion: Mild cognitive impairment is prevalent among older adults with T2DM in this setting. The MMSE is a practical tool for early detection, enabling timely intervention.
References
Aderinto N, Olatunji G, Abdulbasit M, Ashinze P, Faturoti O, Ajagbe A, Ukoaka B, Aboderin G. The impact of diabetes in cognitive impairment: A review of current evidence and prospects for future investigations. Medicine. 2023 Oct 27;102(43):e35557.
Arevalo-Rodriguez I, Smailagic N, Roqué-Figuls M, Ciapponi A, Sanchez-Perez E, Giannakou A, Pedraza OL, Bonfill Cosp X, Cullum S. Mini-Mental State Examination (MMSE) for the early detection of dementia in people with mild cognitive impairment (MCI). Cochrane Database Syst Rev. 2021 Jul 27;7(7).
Arnold SV, Khunti K, Tang F, Chen H, Cid-Ruzafa J, Cooper A, Fenici P, Gomes MB, Hammar N, Ji L, Saraiva GL. Incidence rates and predictors of microvascular and macrovascular complications in patients with type 2 diabetes: results from the longitudinal global discover study. American heart journal. 2022 Jan 1;243:232-9.
Atif M, Saleem Q, Scahill S. Depression and mild cognitive impairment (MCI) among elderly patients with type 2 diabetes mellitus in Pakistan: possible determinants. International Journal of Diabetes in Developing Countries. 2018 Sep;38(3):312-20.
Baek MJ, Kim K, Park YH, Kim S. The validity and reliability of the mini-mental state examination-2 for detecting mild cognitive impairment and Alzheimer’s disease in a Korean population. PloS one. 2016 Sep 26;11(9):e0163792.
Basit, A., Fawwad, A. & Baqa, K. 2019. Pakistan And Diabetes—A Country On The Edge. Diabetes Research And Clinical Practice, 147, 166-168.
Bellary S, Kyrou I, Brown JE, Bailey CJ. Type 2 diabetes mellitus in older adults: clinical considerations and management. Nature Reviews Endocrinology. 2021 Sep;17(9):534-48.
Biessels GJ, Staekenborg S, Brunner E, Brayne C, Scheltens P. Risk of dementia in diabetes mellitus: a systematic review. The Lancet Neurology. 2006 Jan 1;5(1):64-74.
Christiaens A, Henrard S, Zerah L, Dalleur O, Bourdel-Marchasson I, Boland B. Individualisation of glycaemic management in older people with type 2 diabetes: a systematic review of clinical practice guidelines recommendations. Age and Ageing. 2021 Nov;50(6):1935-42.
Cukierman T, Gerstein HC, Williamson JD. Cognitive decline and dementia in diabetes—systematic overview of prospective observational studies. Diabetologia. 2005 Dec;48(12):2460-9.
Damanik J, Yunir E. Type 2 diabetes mellitus and cognitive impairment. Acta Med Indones. 2021 Apr 1;53(2):213-20.
Jia X, Wang Z, Huang F, Su C, Du W, Jiang H, Wang H, Wang J, Wang F, Su W, Xiao H. A comparison of the Mini-Mental State Examination (MMSE) with the Montreal Cognitive Assessment (MoCA) for mild cognitive impairment screening in Chinese middle-aged and older population: a cross-sectional study. BMC psychiatry. 2021 Oct 4;21(1):485.
Kan W, Qu M, Wang Y, Zhang X, Xu L. A review of type 2 diabetes mellitus and cognitive impairment. Frontiers in Endocrinology. 2025 Aug 4;16:1624472.
Michailidis M, Moraitou D, Tata DA, Kalinderi K, Papamitsou T, Papaliagkas V. Alzheimer’s disease as type 3 diabetes: common pathophysiological mechanisms between Alzheimer’s disease and type 2 diabetes. International journal of molecular sciences. 2022 Feb 28;23(5):2687.
Randväli M, Toomsoo T, Šteinmiller J. The main risk factors in type 2 diabetes for cognitive dysfunction, depression, and psychosocial problems: a systematic review. Diabetology. 2024 Jan 11;5(1):40-59.
?wi?toniowska-Lonc N, Pola?ski J, Ta?ski W, Jankowska-Pola?ska B. Impact of cognitive impairment on adherence to treatment and self-care in patients with type 2 diabetes mellitus. Diabetes, Metabolic Syndrome and Obesity. 2021 Jan 15:193-203.
Truong QC, Cervin M, Choo CC, Numbers K, Bentvelzen AC, Kochan NA, Brodaty H, Sachdev PS, Medvedev ON. Examining the validity of the Mini?Mental State Examination (MMSE) and its domains using network analysis. Psychogeriatrics. 2024 Mar;24(2):259-71.
Westman EC. Type 2 diabetes mellitus: a pathophysiologic perspective. Frontiers in nutrition. 2021 Aug 10;8:707371.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2026 Natasha Tahir, Hufsa Tariq, Somia Faisal, Hafiz Muahmmed Asim
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
All Articles are made available under a Creative Commons "Attribution-NonCommercial 4.0 International" license. Copyrights on any open-access article published by the Foundation University Journal of Rehabilitation Sciences (FUJRS) are retained by the author(s). FUJRS is an open-access journal that allows free access to its published articles, in addition, to copy and use for research and academic purposes; provided the article is correctly cited. FUJRS does not allow commercial use of the articles published in FUJRS. All articles published represent the view of the author(s) and do not reflect the official policy of FUJRS.
